GLP-1 receptor agonists in Parkinson’s disease: an updated comprehensive systematic review with meta-analysis

GLP-1 receptor agonists in Parkinson’s disease: an updated comprehensive systematic review with meta-analysis

Abstract Previous studies have demonstrated an increased risk of developing Parkinson’s disease (PD) in patients with type 2 diabetes mellitus (T2DM), as well as more severe and rapid motor and non-motor deterioration in diabetic PD patients compared to their non-diabetic counterparts. Additional re...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Mohsen Helal, Hala AbouShawareb, Omarfayez Hussein Abbas, Roaa Haddad, Youmna Zain, Ahmed S. A. Osman, Amr K. Hassan
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Glucagon-like peptide-1 receptor agonists
Parkinson disease
Motor disorders
Humans
Randomized controlled trials
Online Access:https://doi.org/10.1186/s13098-025-01888-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13098-025-01888-1

Similar Items